Shopping Cart
Remove All
Your shopping cart is currently empty
FATP1-IN-2 is a fatty acid transporter protein 1 (FATP1) inhibitor with oral activity for the study of obesity and metabolic diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $499 | - | In Stock |
| Description | FATP1-IN-2 is a fatty acid transporter protein 1 (FATP1) inhibitor with oral activity for the study of obesity and metabolic diseases. |
| Targets&IC50 | FATP1 (human):0.43 μM, FATP1 (mouse):0.39 μM |
| In vivo | FATP1-IN-2 (10 mg/kg; oral; Mice) showed a Cmax value above the mouse IC50 value.[1] FATP1-IN-2 (3, 10, 30 mg/kg; oral; for 4 weeks; Mice) showed no change in the TG content of each tissue at any dose.[1] |
| Molecular Weight | 353.39 |
| Formula | C19H20FN5O |
| Cas No. | 2650944-83-3 |
| Smiles | Cc1nc2ccccn2c1C(=O)CN1CCN(CC1)c1ccc(F)cn1 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (226.38 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (14.15 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.